#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute hepatic failure Uveitis Shprintzen-Goldberg syndrome Vulval cancer Bronchopulmonary dysplasia Desmoid tumour Non-Hodgkin's lymphoma Pleural mesothelioma Hodgkin's disease refractory Rheumatoid arthritis Haemophilia A without inhibitors Pyruvate kinase deficiency anaemia Drug eruption Pyruvate dehydrogenase complex deficiency Adenomatous polyposis coli More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Trials in Disease Progressive multifocal leukoencephalopathy – Basic Information Primary biliary cholangitis Hereditary optic atrophy – Trials in Disease Hepatic angiosarcoma – Treatment Choroid melanoma – Diagnostics Cystic fibrosis lung – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Basic Information Factor VIII deficiency – Treatment Optic glioma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Msv/As Acetylcholine Chloride 2-DEOXY-D-GLUCOSE D5-Ethyl-Beta-D-Glucuronide Aluminium Oxide, Hydrated Botensilimab Lisinopril Enomimeran AMG 732 Dazucorilant Vidofludimus Calcium Dexamethasone Acetate Oxaliplatin Asciminib Nimorazole Atuliflapon Human Coagulation Factor Ii Sodium Hypochlorite Odevixibat PARECOXIB More therapies…

    Learn about Your Condition

    Respiratory distress Rabies Alcohol use disorder Normal pressure hydrocephalus Glomerulonephritis chronic Vulval cancer recurrent Cancer pain Obsessive-compulsive disorder Uveitis Precocious puberty Strongyloidiasis Hydrocephalus Pneumonia chlamydial Stargardt's disease Tertiary adrenal insufficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of Raludotatug Deruxtecan for People with Gastrointestinal Cancers to Evaluate Safety and Effectiveness

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Raludotatug Deruxtecan
    France Spain

  • A Study of Leniolisib Safety and Effectiveness for Immune System Problems in Patients with Common Variable Immunodeficiency

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Leniolisib Phosphate
    Spain

  • A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ocrelizumab
    France Germany Italy Poland Spain

  • A study testing trontinemab compared to placebo in patients with early Alzheimer’s disease including mild cognitive impairment and mild dementia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florbetapir (18F)
    • TRONTINEMAB
    • Florbetaben (18F)
    Denmark France Germany Italy Poland Spain

  • A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Cldn6 Car-T
    • Cldn6 Car-T(A)
    • Cldn6 Rna-Lpx
    Germany The Netherlands Sweden

  • A study testing MK-1167 added to current treatment in patients with mild to moderate Alzheimer’s disease dementia

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Mk-1167
    Italy The Netherlands Spain
Previous Page
1 … 930 931 932 933 934 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!